JOURNEY MEDICAL CORPORATION - COMMON STOCK

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

11 يوليو 2024 16:05:39 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

15 مايو 2024 16:01:52 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

13 مايو 2024 16:01:47 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

07 مايو 2024 08:30:10 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

01 مايو 2024 16:01:30 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

25 أبريل 2024 08:30:48 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

21 مارس 2024 16:01:27 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

18 مارس 2024 08:30:30 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

15 مارس 2024 08:30:01 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

13 مارس 2024 08:30:14 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

05 يناير 2024 08:30:12 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

02 يناير 2024 16:05:30 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea

06 ديسمبر 2023 08:00:51 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

07 نوفمبر 2023 16:01:18 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

31 أكتوبر 2023 08:30:12 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)

20 أكتوبر 2023 08:30:59 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations

06 سبتمبر 2023 08:00:04 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

08 أغسطس 2023 16:01:33 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results on August 8, 2023

02 أغسطس 2023 16:01:42 بحسب Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023

19 يوليو 2023 08:30:00 بحسب Nasdaq GlobeNewswire